SynthesisJournal of global health2026
Innovative virtual reality exposure therapy for anxiety and posttraumatic stress disorder: a meta-analysis of randomised controlled trials.
Synthesis in Journal of global health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anxiety disorders impose a substantial burden on individuals and society, affecting mental health, quality of life, and health care systems. Virtual reality exposure therapy (VRET) has emerged as a promising treatment. However, existing meta-analyses often included participants without clinically diagnosed anxiety or related disorders. This study aimed to evaluate the efficacy of VRET in reducing anxiety, phobia, behavioural symptoms, and posttraumatic stress disorder (PTSD) among patients with anxiety-related disorders and PTSD. Methods: A systematic search was conducted across seven databases - CINAHL, Embase, PubMed, PsycINFO, Web of Science, Cochrane Library, and Medline-OVID. Eligible studies included randomised controlled trials (RCTs) examining the effects of VRET on anxiety-related outcomes. Data were pooled using a random-effects model with Comprehensive Meta-Analysis (version 3.0; Biostat, Englewood, NJ, USA). Effect size were calculated using Hedges' g, and moderator analyses explored potential factors influencing the effect sizes. Results: Twenty-six RCTs involving 1649 participants met the inclusion criteria. Overall, VRET demonstrated significant and clinically meaningful effects across multiple domains. It reduced phobia symptoms (Hedges' g = -0.98; 95% confidence interval (CI) = -1.37, -0.60, P < 0.001), increased approach behaviour (Hedges' g = 0.62; 95% CI = 0.11, 1.12, P = 0.02), alleviated anxiety symptoms (Hedges' g = -0.61; 95% CI = -0.90, -0.33, P < 0.001), and mitigated PTSD symptoms (Hedges' g = -0.51; 95% CI = -0.72, -0.30, P < 0.001). Moderator analyses indicated that shorter intervention durations (<60 minutes) were associated with larger treatment effects on anxiety and phobia. VR-based Cognitive Behavioral Therapy (VR-CBT) and VRET demonstrated large and significant effects for phobia. Conclusions: VRET effectively reduces anxiety, phobia, and PTSD symptoms while enhancing approach behaviour in clinically diagnosed patients. Its immersive and adaptable features make it a valuable exposure-based treatment tool. Further RCTs using advanced VR technologies and standardised protocols are needed to strengthen the evidence and optimise clinical application. Registration: Open Science Framework (https://doi.org/10.17605/OSF.IO/AD4M2).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.